Matches in SemOpenAlex for { <https://semopenalex.org/work/W1949673766> ?p ?o ?g. }
Showing items 1 to 90 of
90
with 100 items per page.
- W1949673766 endingPage "1891" @default.
- W1949673766 startingPage "1885" @default.
- W1949673766 abstract "Forty patients with metastatic, recurrent, or unresectable renal cell carcinoma were entered into a study of the therapeutic efficacy of adoptive immunotherapy using periodate (IO4-) and interleukin-2 (IL2)-activated autologous leukocytes and continuous infusion low-dose IL2. Patient survival was also examined. The first 15 consecutive patients were enrolled in protocol A without an IL2 priming phase and the following 25 patients were entered in protocol B where a 5-day priming phase was initiated before leukapheresis. A maintenance regimen consisted of either 3 x 10(6) units of recombinant interferon-alpha (rIFN-alpha), three times per week only or together with leukapheresis and infusion of IO4-/IL2-activated cells and 2 days of continuous infusion IL2 per month. Thirty-four patients completed the protocol treatment. Four patients were removed from the study owing to rapid tumor progression and two patients died while receiving treatment. The clinical response rate was 22%: two patients had a complete response and five patients had a partial response. Among the 25 patients who had no clinical response, 11 patients had either a mixed response or stabilization. Neither response, response duration, nor site response correlated with the total dose of IL2 administered or the number of activated killer cells infused. Patients who received maintenance therapy had longer survival times than patients who did not receive such therapy. All toxicity and side effects associated with IL2 treatment were transient and resolved after discontinuation of the drug. Patients on maintenance therapy tolerated both rIFN-alpha and monthly infusions of activated killer cells and IL2 well. This study confirms the concept of adoptive immunotherapy as a new treatment approach for advanced renal cell carcinoma and suggests that maintenance therapy may prolong survival time." @default.
- W1949673766 created "2016-06-24" @default.
- W1949673766 creator A5018907838 @default.
- W1949673766 creator A5026765815 @default.
- W1949673766 creator A5040319294 @default.
- W1949673766 creator A5040941721 @default.
- W1949673766 creator A5060505506 @default.
- W1949673766 creator A5070626557 @default.
- W1949673766 creator A5072273344 @default.
- W1949673766 creator A5073533672 @default.
- W1949673766 date "1989-12-01" @default.
- W1949673766 modified "2023-09-25" @default.
- W1949673766 title "A phase II clinical trial of adoptive immunotherapy for advanced renal cell carcinoma using mitogen-activated autologous leukocytes and continuous infusion interleukin-2." @default.
- W1949673766 cites W1529386421 @default.
- W1949673766 cites W153538655 @default.
- W1949673766 cites W1634065958 @default.
- W1949673766 cites W1985981664 @default.
- W1949673766 cites W2051636382 @default.
- W1949673766 cites W2063442867 @default.
- W1949673766 cites W2097626107 @default.
- W1949673766 cites W2149724818 @default.
- W1949673766 cites W2322553446 @default.
- W1949673766 cites W2326245275 @default.
- W1949673766 doi "https://doi.org/10.1200/jco.1989.7.12.1885" @default.
- W1949673766 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/2555451" @default.
- W1949673766 hasPublicationYear "1989" @default.
- W1949673766 type Work @default.
- W1949673766 sameAs 1949673766 @default.
- W1949673766 citedByCount "30" @default.
- W1949673766 crossrefType "journal-article" @default.
- W1949673766 hasAuthorship W1949673766A5018907838 @default.
- W1949673766 hasAuthorship W1949673766A5026765815 @default.
- W1949673766 hasAuthorship W1949673766A5040319294 @default.
- W1949673766 hasAuthorship W1949673766A5040941721 @default.
- W1949673766 hasAuthorship W1949673766A5060505506 @default.
- W1949673766 hasAuthorship W1949673766A5070626557 @default.
- W1949673766 hasAuthorship W1949673766A5072273344 @default.
- W1949673766 hasAuthorship W1949673766A5073533672 @default.
- W1949673766 hasConcept C10205521 @default.
- W1949673766 hasConcept C121608353 @default.
- W1949673766 hasConcept C126322002 @default.
- W1949673766 hasConcept C141071460 @default.
- W1949673766 hasConcept C2777371288 @default.
- W1949673766 hasConcept C2777371436 @default.
- W1949673766 hasConcept C2777472916 @default.
- W1949673766 hasConcept C2777701055 @default.
- W1949673766 hasConcept C2778690821 @default.
- W1949673766 hasConcept C2781413609 @default.
- W1949673766 hasConcept C28328180 @default.
- W1949673766 hasConcept C54355233 @default.
- W1949673766 hasConcept C71924100 @default.
- W1949673766 hasConcept C86803240 @default.
- W1949673766 hasConcept C90924648 @default.
- W1949673766 hasConceptScore W1949673766C10205521 @default.
- W1949673766 hasConceptScore W1949673766C121608353 @default.
- W1949673766 hasConceptScore W1949673766C126322002 @default.
- W1949673766 hasConceptScore W1949673766C141071460 @default.
- W1949673766 hasConceptScore W1949673766C2777371288 @default.
- W1949673766 hasConceptScore W1949673766C2777371436 @default.
- W1949673766 hasConceptScore W1949673766C2777472916 @default.
- W1949673766 hasConceptScore W1949673766C2777701055 @default.
- W1949673766 hasConceptScore W1949673766C2778690821 @default.
- W1949673766 hasConceptScore W1949673766C2781413609 @default.
- W1949673766 hasConceptScore W1949673766C28328180 @default.
- W1949673766 hasConceptScore W1949673766C54355233 @default.
- W1949673766 hasConceptScore W1949673766C71924100 @default.
- W1949673766 hasConceptScore W1949673766C86803240 @default.
- W1949673766 hasConceptScore W1949673766C90924648 @default.
- W1949673766 hasIssue "12" @default.
- W1949673766 hasLocation W19496737661 @default.
- W1949673766 hasLocation W19496737662 @default.
- W1949673766 hasOpenAccess W1949673766 @default.
- W1949673766 hasPrimaryLocation W19496737661 @default.
- W1949673766 hasRelatedWork W2006169817 @default.
- W1949673766 hasRelatedWork W2011646157 @default.
- W1949673766 hasRelatedWork W2018333422 @default.
- W1949673766 hasRelatedWork W2020226094 @default.
- W1949673766 hasRelatedWork W2151709130 @default.
- W1949673766 hasRelatedWork W2231122713 @default.
- W1949673766 hasRelatedWork W2324871003 @default.
- W1949673766 hasRelatedWork W2494898484 @default.
- W1949673766 hasRelatedWork W3031648790 @default.
- W1949673766 hasRelatedWork W2408263508 @default.
- W1949673766 hasVolume "7" @default.
- W1949673766 isParatext "false" @default.
- W1949673766 isRetracted "false" @default.
- W1949673766 magId "1949673766" @default.
- W1949673766 workType "article" @default.